Mohamed El‐Kassas

15.0k total citations · 1 hit paper
214 papers, 2.8k citations indexed

About

Mohamed El‐Kassas is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Mohamed El‐Kassas has authored 214 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Epidemiology, 113 papers in Hepatology and 20 papers in Infectious Diseases. Recurrent topics in Mohamed El‐Kassas's work include Liver Disease Diagnosis and Treatment (114 papers), Hepatitis C virus research (82 papers) and Hepatitis B Virus Studies (59 papers). Mohamed El‐Kassas is often cited by papers focused on Liver Disease Diagnosis and Treatment (114 papers), Hepatitis C virus research (82 papers) and Hepatitis B Virus Studies (59 papers). Mohamed El‐Kassas collaborates with scholars based in Egypt, Saudi Arabia and United States. Mohamed El‐Kassas's co-authors include Gamal Esmat, Tamer Elbaz, Aisha Elsharkawy, Imam Waked, Mohamed Eltabbakh, Mohamed Hassany, Mohammed A. Medhat, Naglaa Allam, Asmaa Gomaa and Wahid Doss and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Mohamed El‐Kassas

183 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of metabolic dysfunction‐associated steatotic liver disease in the Middle East and North Africa

2024 43 citations Zobair M. Younossi, James M. Paik et al. Liver International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohamed El‐Kassas Egypt	30	1.3k	1.3k	354	248	237	214	2.8k
Mária Papp Hungary	32	1.3k 1.0×	673 0.5×	275 0.8×	96 0.4×	123 0.5×	169	3.0k
Frédéric Dubois France	37	1.5k 1.2×	1.6k 1.3×	2.3k 6.4×	88 0.4×	225 0.9×	157	5.5k
Miguel Á. Casado Spain	26	498 0.4×	412 0.3×	394 1.1×	367 1.5×	53 0.2×	129	2.2k
Jean‐Pierre Pascal France	28	1.6k 1.2×	1.8k 1.4×	108 0.3×	178 0.7×	27 0.1×	69	2.9k
Martine De Vos Belgium	35	935 0.7×	350 0.3×	47 0.1×	69 0.3×	226 1.0×	109	4.9k
Akira Hasegawa Japan	32	782 0.6×	438 0.3×	134 0.4×	33 0.1×	300 1.3×	196	4.5k
Yibo Ding China	27	172 0.1×	89 0.1×	179 0.5×	219 0.9×	155 0.7×	95	2.4k
Xiaoli Yan China	22	262 0.2×	112 0.1×	214 0.6×	227 0.9×	24 0.1×	83	1.9k
Marı́a del Pilar Dı́az Argentina	24	205 0.2×	63 0.1×	179 0.5×	129 0.5×	86 0.4×	117	2.0k
Peter A Bonis United States	25	424 0.3×	325 0.3×	272 0.8×	69 0.3×	22 0.1×	88	3.3k

Countries citing papers authored by Mohamed El‐Kassas

Since Specialization

Citations

This map shows the geographic impact of Mohamed El‐Kassas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed El‐Kassas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed El‐Kassas more than expected).

Fields of papers citing papers by Mohamed El‐Kassas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed El‐Kassas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed El‐Kassas. The network helps show where Mohamed El‐Kassas may publish in the future.

Co-authorship network of co-authors of Mohamed El‐Kassas

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed El‐Kassas. A scholar is included among the top collaborators of Mohamed El‐Kassas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed El‐Kassas. Mohamed El‐Kassas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shousha, Hend Ibrahim, et al.. (2025). Personalized treatment approaches in hepatocellular carcinoma. Arab Journal of Gastroenterology. 26(1). 122–128.

Zelber‐Sagi, Shira, James M. Paik, Dana Ivancovsky‐Wajcman, et al.. (2025). “Weekend Warrior” Exercise Pattern Protects Against MASLD and Mortality Comparable to Regular Exercise: National Cohort Study. Liver International. 45(8). e70226–e70226. 1 indexed citations

Yu, Daojiang, Teng Xie, Yuhao Wang, et al.. (2025). Cordycepin alleviates metabolic dysfunction-associated liver disease by restoring mitochondrial homeostasis and reducing oxidative stress via Parkin-mediated mitophagy. Biochemical Pharmacology. 232. 116750–116750. 4 indexed citations

Elbaz, Tamer, Khalid Al‐Naamani, Hazem Abosheaishaa, Khalid Alswat, & Mohamed El‐Kassas. (2025). Leading Role of Sofosbuvir/Daclatasvir in Achieving Hepatitis C Elimination in Egypt. Journal of Viral Hepatitis. 32(7). e70032–e70032.

Hetta, ‏Helal F., et al.. (2025). Challenges and Recent Advances in Diagnosing Wilson Disease. Journal of Clinical and Experimental Hepatology. 15(4). 102531–102531. 2 indexed citations

Hashem, Mohamed, et al.. (2024). Drug-induced liver injury during the era of COVID-19 polypharmacy: a statement of account, lessons learned, and a proposed approach. SHILAP Revista de lepidopterología. 14(1). 1 indexed citations

El‐Kassas, Mohamed, Wafaa Elakel, Aisha Elsharkawy, et al.. (2024). Comparison of different noninvasive scores for assessing hepatic fibrosis in a cohort of chronic hepatitis C patients. Scientific Reports. 14(1). 29544–29544. 1 indexed citations

Abosheaishaa, Hazem, et al.. (2024). The Egyptian journey from having the highest prevalence of hepatitis C virus to being the first to achieve “gold tier” in conquering the disease. Baylor University Medical Center Proceedings. 37(5). 877–883. 1 indexed citations

Alqahtani, Saleh A., Yusuf Yılmaz, Mohamed El‐Kassas, et al.. (2024). Clinical and patient‐reported outcomes in patients with chronic hepatitis B and C and non‐alcoholic fatty liver disease from real‐world practices in Saudi Arabia, Turkey and Egypt. Journal of Viral Hepatitis. 31(6). 300–308. 4 indexed citations

10.

Alqahtani, Saleh A., Yusuf Yılmaz, Mohamed El‐Kassas, et al.. (2024). Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region. Annals of Hepatology. 30(1). 101569–101569. 6 indexed citations

11.

El‐Kassas, Mohamed, et al.. (2023). Diagnosis, treatment protocols, and outcomes of liver transplant recipients infected with COVID-19. World Journal of Clinical Cases. 11(10). 2140–2159. 2 indexed citations

12.

Elsharkawy, Aisha, et al.. (2023). The implications of the COVID-19 pandemic on hepatitis B and C elimination programs in Egypt: current situation and future perspective. SHILAP Revista de lepidopterología. 13(1). 3 indexed citations

13.

Tawheed, Ahmed, Mohamed El‐Kassas, Amr El Fouly, & Gamal Esmat. (2023). Predictors of Treatment Failure with Sofosbuvir/Daclatasvir Regimen for 12 Weeks in Patients with Chronic HCV in Egypt. International Journal of TROPICAL DISEASE & Health. 57–64. 1 indexed citations

14.

Younossi, Zobair M., Yusuf Yılmaz, Mohamed El‐Kassas, et al.. (2022). The impact of the COVID‐19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry. Hepatology Communications. 6(10). 2860–2866. 3 indexed citations

15.

Agwa, Sara H. A., et al.. (2021). Circulatory Endothelin 1-Regulating RNAs Panel: Promising Biomarkers for Non-Invasive NAFLD/NASH Diagnosis and Stratification: Clinical and Molecular Pilot Study. Genes. 12(11). 1813–1813. 11 indexed citations

16.

El‐Kassas, Mohamed, Mohamed Alboraie, Naglaa Youssef, et al.. (2020). Retreatment of chronic hepatitis C patients who failed previous therapy with directly acting antivirals: A multicenter study. International Journal of Infectious Diseases. 96. 367–370. 5 indexed citations

17.

El‐Kassas, Mohamed, Mohamed Alboraie, Mervat Naguib, et al.. (2019). A significant upsurge of body mass index in patients with chronic hepatitis C successfully treated with direct-acting antiviral regimens. The Turkish Journal of Gastroenterology. 30(8). 708–713. 11 indexed citations

18.

El‐Kassas, Mohamed, Ahmed Tawheed, Mohamed Eltabbakh, & Ahmed O. Kaseb. (2019). <p>Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves</p>. Journal of Hepatocellular Carcinoma. Volume 6. 183–191. 11 indexed citations

19.

El‐Kassas, Mohamed, Dalia Omran, Kadry Elsaeed, et al.. (2018). Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience. Journal of Interferon & Cytokine Research. 38(2). 81–85. 5 indexed citations

20.

Esmat, Gamal, Maissa El Raziky, Aisha Elsharkawy, et al.. (2014). Impact of Vitamin D Supplementation on Sustained Virological Response in Chronic Hepatitis C Genotype 4 Patients Treated by Pegylated Interferon/Ribavirin. Journal of Interferon & Cytokine Research. 35(1). 49–54. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact